Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Nuvigil

Nuvigil
In stock
100mg · 200mg
from A$66.79
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$80.15A$66.79
A$2.23 per tablet

In brief

  • In our pharmacy, you can buy nuvigil without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Nuvigil (armodafinil) is used to promote wakefulness for conditions such as narcolepsy; it enhances central nervous system wakefulness via effects on monoaminergic systems (the exact mechanism is not fully understood but includes inhibition of dopamine reuptake and increased histamine/orexin activity). Historically related wakefulness indications have included obstructive sleep apnoea–related sleepiness and shift work sleep disorder in some labels.
  • The usual dose for wakefulness-promoting agents in this class is typically 200 mg once daily for modafinil; for armodafinil (Nuvigil) a common adult dose is 150 mg once daily in the morning (doses may be adjusted by a clinician; higher doses have been used but additional benefit is inconsistent).
  • The form of administration is an oral tablet.
  • The effect usually begins within 30–60 minutes after ingestion.
  • The duration of action is generally about 10–12 hours (armodafinil may have effects lasting up to around 12–15 hours in some people).
  • Do not consume alcohol — alcohol can worsen side effects such as dizziness, sleep disruption and impaired judgement.
  • The most common side effect is headache; other common adverse effects include nausea, nervousness, insomnia, anxiety and rash.
  • Would you like to try nuvigil without a prescription?

Basic Nuvigil Information

  • INN (International Nonproprietary Name): modafinil
  • Brand Names Available In Australia: Provigil, Modiodal, Modasomil, Vigil
  • ATC Code: N06BA07
  • Forms & Dosages: Tablets 100 mg and 200 mg
  • Manufacturers In Australia: not specified
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: Prescription-only (Rx)

Critical Warnings, Restrictions And Patient Protection (Safety First)

Patients often ask, “Is this safe for me?” and that is the right question to start with.

Hypersensitivity to modafinil, armodafinil or any excipient is an absolute contraindication.

There are important psychiatric and cardiovascular risks to screen for before prescribing or dispensing.

Severe hepatic impairment requires dose reduction; manufacturer guidance notes 100 mg once daily for severe hepatic impairment.

Do not start or continue without a focused safety check in high‑risk people.

High‑Risk Groups (Pregnancy, Elderly, Chronic Illness)

Pregnant or breastfeeding patients need a clear risk–benefit discussion with their prescriber.

Elderly patients should start cautiously and be monitored closely for cardiovascular and psychiatric adverse effects.

People with uncontrolled cardiovascular disease, arrhythmias or uncontrolled hypertension require cardiology review before use.

Patients with current or past psychosis, mania or suicidal ideation require specialist input and close monitoring.

A history of severe rash, angio‑oedema or anaphylaxis is a reason to avoid modafinil or armodafinil unless advised otherwise by a specialist.

  • Screening checklist at point of care:
  • Pregnancy test if applicable and contraception discussion for women of childbearing potential.
  • Blood pressure check and ECG if there is any cardiac history or concern.
  • Complete current medicines list to assess interactions and competing stimulants.
  • Mental‑health history including past psychosis, mania or suicidal thoughts.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Wakefulness agents change patterns of alertness but do not remove the risk of sudden sleep episodes in everyone.

Patients must assess fitness to drive based on how the medicine affects their alertness, with input from their prescriber or occupational health.

Employers and safety officers should be involved where workplace safety could be affected by residual sleepiness or unexpected drowsiness.

Documented assessments of fitness to drive or work are important under Australian occupational and road‑safety expectations.

Q&A — “Can I Drive After Taking Nuvigil/Modafinil?”

No automatic clearance is given for driving after taking modafinil or armodafinil.

If the medicine reduces your sleepiness without causing dizziness, marked insomnia or sudden sleep attacks, and you can demonstrate safe driving, you may drive.

If you experience dizziness, confusion, severe insomnia or any episodes of sudden sleep, do not drive and contact your prescriber.

Ask the prescriber to document a fitness‑to‑drive assessment in your record if driving is essential for work or home life.

Usage Basics: Names, Classification, Legal Status In Australia

INN, Brand Names And What Nuvigil Is

Provigil is the brand name for modafinil and is a prescription wakefulness‑promoting medicine used mainly for narcolepsy.

Internationally, similar names seen in public regulatory data include Provigil, Modiodal, Modasomil and Vigil.

Nuvigil is the brand name for armodafinil, which is the R‑enantiomer related to modafinil and may have different pharmacokinetic properties.

Check local TGA entries for exact approvals and any differences between armodafinil and modafinil for specific brands.

Legal Classification (TGA Approval, PBS Listing, Prescription Status)

Modafinil products are prescription‑only medicines in the referenced product information.

Confirm TGA registration on the ARTG and check the PBS schedule for any subsidy or authority requirements for the exact product and indication.

ATC code for modafinil is N06BA07, which places it in psychoanaleptics and other psychostimulants and nootropics.

  • Definitions:
  • INN = international nonproprietary name, the generic name (example: modafinil).
  • Brand = trade name under which a product is marketed (example: Provigil, Nuvigil).
  • ATC code = Anatomical Therapeutic Chemical classification; modafinil is N06BA07.

Dosing Guide (Standard Regimens And Adjustments)

Standard Adult Regimens

Typical adult dose from public product information is 200 mg once daily in the morning for narcolepsy and obstructive sleep apnoea‑related sleepiness where indicated.

For shift‑work disorder, the usual recommendation in product information is 200 mg taken approximately one hour before the start of the shift.

Tablets commonly come as 100 mg and 200 mg strengths to allow flexible dosing.

Adjustments For Comorbidities And Special Populations

Reduce dose in moderate to severe hepatic impairment; manufacturer summaries note 100 mg once daily for severe hepatic impairment.

Children: many product references state modafinil is not approved for paediatric use.

Elderly patients should start at cautious doses and be observed closely for cardiovascular or psychiatric adverse effects.

Renal dosing guidance was not specified in the available product snippets, so individual review is prudent where renal impairment exists.

Q&A — “What If I Miss A Dose?”

If you miss a morning dose, skip taking it later in the day to avoid insomnia.

For shift‑work disorder, if the pre‑shift dose is missed do not take it mid‑shift.

  • Do confirm with your prescriber for personalised advice.
  • Do skip a late dose to reduce the chance of sleep disturbance that night.
  • Don’t double up or take an extra dose to “catch up.”

Interaction Chart — Food, Alcohol, Caffeine And Common Drug Conflicts

Food And Drink Considerations

Alcohol can worsen sleep architecture and may increase adverse effects when combined with wakefulness agents.

Mixing alcohol and modafinil is not recommended until drug tolerance and interactions are assessed under medical advice.

Caffeine adds to stimulant effects and may increase nervousness, palpitations or insomnia when used with modafinil or armodafinil.

Substance Likely Interaction Practical Advice
Alcohol May increase sedation variability and worsen sleep quality; may potentiate adverse effects. Avoid until you know how the medicine affects you; discuss with prescriber.
Caffeine Additive stimulant effects; possible increased anxiety or insomnia. Limit intake if you experience jitteriness or sleep problems.
High‑fat meals Food may modestly affect absorption timing. Take consistently with or without food to maintain routine.

Common Drug Interactions To Flag

Ask patients to bring a full list of medicines, including vitamins, herbal products and oral contraceptives.

Modafinil is known to induce or affect certain liver enzymes and can reduce exposure for some medicines, including some hormonal contraceptives.

Other stimulants, certain antidepressants and enzyme‑inducing or inhibiting drugs are high‑risk classes to check.

  • High‑risk drug classes to review: hormonal contraceptives, strong CYP inducers/inhibitors, amphetamine‑type stimulants, some antipsychotics and certain antidepressants.
  • Recommend a pharmacist medication review and use of interaction‑checking software at the point of dispensing.

User Reports And Trends In Australia

Patients commonly report improved daytime wakefulness for narcolepsy and for some with shift‑work disorder.

Many users find benefit at 200 mg daily and report inconsistent additional benefit from higher doses.

Typical side‑effect complaints include headache, nausea, insomnia and anxiety.

Cost sensitivity is a frequent theme in Australian forums and review sites, with reliance on PBS subsidy where available.

Pharmacovigilance signals Australians should report include serious skin reactions such as Stevens–Johnson syndrome, new or worsening psychiatric symptoms and cardiovascular events.

Report suspected adverse reactions through the TGA adverse event portal to support safety monitoring.

  • What Patients Often Report
  • Positive effects: reduced daytime sleepiness, improved alertness for work or study.
  • Common side effects: headache, nausea, nervousness, insomnia, anxiety.
  • Practical issues: cost, need for specialist review and concern about interactions with contraception.
Positive Effects Common Side Effects Action To Take
Better daytime wakefulness Headache, nausea Report persistent symptoms to prescriber; consider dose review
Improved shift performance Insomnia, anxiety Avoid late dosing; discuss sleep hygiene
Functional gains at work Rare severe rash or psychiatric changes Stop medication and seek urgent care if severe rash or suicidal thoughts occur

Access And Purchase Options In Australia

Where To Get A Legitimate Prescription And Supply

The usual public route is a consultation with a GP or specialist who can write a prescription.

PBS may subsidise eligible patients depending on the listed product and authority requirements, so check the PBS schedule for item numbers and restrictions.

Community pharmacies including large chains and independent pharmacies supply prescription medicines; stock and brand availability can vary by location.

Online Pharmacies And Telehealth

E‑prescriptions and telehealth consultations are common and convenient, particularly for rural patients.

Ensure any online pharmacy is Australian‑regulated and requires a valid prescription before dispensing.

For rural patients, pharmacies may need to order stock in advance so plan ahead for continuous supply.

  • Steps To Access
  • 1) Consult a prescriber to confirm diagnosis and suitability.
  • 2) Check PBS eligibility and any authority requirements.
  • 3) Choose an accredited pharmacy in person or online.
  • 4) Verify dispensing, counselling and follow‑up arrangements.

In our online pharmacy, nuvigil is available without a prescription, with discreet delivery to Australia in 9‑21 days.

Mechanism Of Action And Pharmacology (Simple + Clinical)

Simplified Explanation

Modafinil and armodafinil are wakefulness‑promoting agents that act on multiple wake‑promoting systems in the brain, including dopaminergic pathways, without a classic amphetamine‑type action.

ATC code N06BA07 groups modafinil with other psychostimulants and nootropics.

Clinical Pharmacology Points Clinicians Need

Modafinil typically has an onset consistent with morning dosing and armodafinil may have slightly different half‑life characteristics that influence timing.

Document baseline sleepiness scales, blood pressure and heart rate where indicated, and perform psychiatric screening prior to starting therapy.

  • Mechanism Terms
  • Dopaminergic modulation = affects dopamine signalling related to wakefulness.
  • Non‑amphetamine stimulant = wakefulness without the typical amphetamine profile.
Drug Onset Typical Monitoring
Modafinil Onset within hours of morning dose Sleepiness scales, BP/HR if cardiac risk, psychiatric review
Armodafinil Similar onset; half‑life differences may change duration As above; monitor daytime sleepiness and side effects

Indications And Off‑Label Uses In Australian Practice

Approved Indications (What Product Data Shows)

Core indication for Provigil/modafinil in many jurisdictions is excessive daytime sleepiness associated with narcolepsy.

Some product labels historically included obstructive sleep apnoea and shift‑work disorder, though regulatory decisions in some regions narrowed indications to narcolepsy only.

Off‑Label Uses And Clinical Caution

Off‑label uses reported internationally include residual sleepiness despite optimised OSA therapy, cognitive fatigue syndromes and certain neurological indications.

Such uses should only proceed with specialist oversight and clear documentation of benefit and risk.

  • Indication Suitability Checklist
  • Confirmed diagnosis with objective and subjective measures of daytime sleepiness.
  • Optimisation of primary therapy first (for example, CPAP for OSA).
  • Clear documentation of alternatives tried and expected outcomes.

Key Clinical Findings And Evidence Summary (Australia & International)

Randomised trials and clinical data show wakefulness agents improve objective and subjective measures of daytime sleepiness in narcolepsy and, depending on the trial, in shift‑work disorder and residual OSA sleepiness.

Doses above 200 mg/day provide inconsistent additional benefit while adverse‑event rates increase with higher doses in some reports.

Common adverse events include headache, nausea, insomnia and anxiety.

Rare but serious reactions include severe dermatological and psychiatric events that require immediate attention.

Outcome Evidence Strength Clinical Note
Reduction in daytime sleepiness Moderate–High Monitor sleepiness scales and adjust therapy as needed
Additional benefit >200 mg/day Low–Inconsistent Weigh risks before increasing dose beyond typical range
Serious skin/psychiatric reactions Low but clinically important Stop medication and seek urgent assessment if these occur

Australian clinicians should monitor emerging safety signals and consult up‑to‑date TGA and PBS guidance alongside recent peer‑reviewed trials when setting local policy.

Alternatives Matrix And Pros/Cons

PBS‑Listed Alternatives And Comparison

Alternatives in clinical practice include armodafinil (Nuvigil) and stimulant options such as methylphenidate or dexamphetamine, each with different regulatory approvals, efficacy profiles and side‑effect considerations.

Stimulant alternatives may have higher abuse potential and different cardiovascular and psychiatric risk profiles, requiring specialist oversight.

Drug Indication Typical Dose PBS Status Key Adverse Effects Practical Notes
Modafinil Narcolepsy (and where labelled) 200 mg once daily Varies by product; check PBS Headache, insomnia, anxiety, rash Lower classical stimulant profile; check interactions
Armodafinil Narcolepsy / SWD where indicated Typical dosing per product Varies by product; check PBS Similar to modafinil; monitor carefully R‑enantiomer; may differ in duration
Methylphenidate Selected cases of excessive sleepiness Individualised PBS for certain indications Stimulant effects, abuse potential Require specialist prescribing in many cases

Pros And Cons Checklist

  • Efficacy for excessive sleepiness: generally good for narcolepsy at standard doses.
  • Abuse potential: lower for modafinil than classic stimulants but still requires monitoring.
  • Cardiovascular risk: assess history, monitor BP and ECG where indicated.
  • Psychiatric effects: watch for new or worsening psychiatric symptoms.
  • PBS subsidy implications: check item numbers and authority requirements when cost is a concern.

Common Patient Questions (Pharmacy FAQs)

Will this fix my narcolepsy?

It improves wakefulness and daytime alertness but is not a cure for narcolepsy.

Can I drink alcohol?

Alcohol is not recommended while establishing tolerance or when taking modafinil due to interaction and sleep‑architecture concerns.

What if I’m pregnant?

Use only when clearly necessary and after discussion of risks and benefits with the prescriber.

How long before effect?

Take in the morning for daytime schedules or about one hour before a work shift for shift‑work disorder.

  • Rapid Counselling Points
  • Take in the morning; avoid late dosing to reduce insomnia.
  • Bring a current medicines list to every dispense.
  • Report rash, chest pain, fainting or new psychiatric symptoms immediately.

Pharmacists should document counselling and report adverse events to the TGA as part of routine pharmacovigilance.

Price And Access Comparison (Table And Checklist)

Pharmacy/Source Vs Price Vs PBS

Out‑of‑pocket costs vary by brand, pack size and whether PBS authority applies.

Because prices change, patients should check current pharmacy quotes for up‑to‑date pricing information.

Pharmacy Brand PBS Subsidy? Typical Out‑Of‑Pocket Band Prescription Required
Chemist Warehouse Provigil / modafinil brands Varies Check with pharmacy Yes
Priceline Provigil / equivalents Varies Check with pharmacy Yes
TerryWhite Chemmart Provigil / equivalents Varies Check with pharmacy Yes
Independent Pharmacies Various brands Varies Check with pharmacy Yes

Access Checklist

  • Confirm prescription and any PBS authority requirements.
  • Compare local versus online pharmacy stock and service.
  • Check PBS concession eligibility for savings.
  • Plan supply for rural patients to avoid missed doses.
  • Ensure pharmacist counselling is provided at dispensing.

Registration, Regulation And Reporting In Australia

TGA And PBS Roles

Check the Australian Register of Therapeutic Goods (ARTG) to confirm TGA registration for the specific modafinil or armodafinil product.

PBS listing determines subsidy and may require authority prescriptions for subsidised access.

Safety Reporting And Pharmacovigilance

Encourage reporting of adverse events to the TGA and keep clear medical records for each dispensed patient.

Imported or compounded supplies must comply with ARTG requirements and local regulations.

  • Checklist: ARTG check, PBS item and authority check, adverse‑event reporting link, local prescribing limits and restrictions.

Storage, Handling And Dispensing Considerations (Household & Pharmacy)

Household Storage For Australian Climate

Keep in the original packaging at room temperature and protect from moisture and heat.

Avoid storing medication in cars or bathrooms where heat and humidity can be high, especially in Australian summers.

Pharmacy Cold‑Chain And Dispensing

No special cold chain is required for modafinil or armodafinil.

Pharmacies should ensure secure storage, stock rotation and clear labelling with counselling at the time of dispense.

  • Checklist For Dispensed Packs:
  • Verify patient identity and provide written information.
  • Counsel on dosing time, missed dose rules and adverse effects to watch for.
  • Advise on safe disposal of unused medicines.

Guidelines For Proper Use And Pharmacist Counselling (Australian Style)

Counselling Checklist For Pharmacists

Confirm the indication and verify diagnosis and that primary therapy has been optimised where relevant.

Screen for pregnancy and breastfeeding, measure blood pressure and take a focused cardiac history where indicated.

Obtain a mental‑health history including past psychosis, mania or suicidal ideation.

Discuss dosing and timing: typically 200 mg in the morning or about one hour before a night shift for shift‑work disorder.

Review drug interactions and explain common side effects and emergency signs such as severe rash, chest pain or suicidal thoughts.

Patient Handout Items And Follow‑Up

Provide a one‑page handout summarising what the medicine treats, how and when to take it, key interactions and when to stop and call the prescriber.

Include definitions of terms such as narcolepsy, shift‑work disorder and obstructive sleep apnoea for patient understanding.

  • Follow‑Up Checklist: Review at 1–4 weeks after start, then regular reviews to assess efficacy and adverse effects.
  • Document counselling and any adverse‑event reports to the TGA.
  • Refer to specialist sleep or neurology services if uncertain or if response is suboptimal.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Sunshine Coast Queensland 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days

Related products